Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DAVIS, RUTH A | 1 | 60.8% | +31.2% |
| MALDONADO, STEVEN | 1 | 30.4% | +46.2% |
| NGUYEN, QUANG | 1 | 38.1% | +53.0% |
| RAMOS LEWIS, JOSMALEN MILAGROS | 1 | 54.7% | +22.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18555381 | SYSTEMS, APPARATUS AND METHODS FOR DETERMINING ANEURYSM AND ARTERIAL WALL ENHANCEMENT | MALDONADO, STEVEN | 36d overdue |
| 17772450 | FORMULATION FOR DELIVERY OF LUBRICIN GENE | NGUYEN, QUANG | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18555381 | SYSTEMS, APPARATUS AND METHODS FOR DETERMINING ANEURYSM AND ARTERIAL WALL ENHANCEMENT | MALDONADO, STEVEN | 36d overdue |
| 17436042 | COMPOSITION COMPRISING AN ANTI-OXIDANT TO PRESERVE CORNEAL TISSUE | RAMOS LEWIS, JOSMALEN MILAGROS | 34d |
| 18563088 | ANTI-OXIDANT CONTAINING PARTICLES AND METHODS OF USE | DAVIS, RUTH A | — |
| 17772450 | FORMULATION FOR DELIVERY OF LUBRICIN GENE | NGUYEN, QUANG | — |
| Art Unit | Apps |
|---|---|
| 1699 | 1 |
| 3797 | 1 |
| 1631 | 1 |
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18563088 | ANTI-OXIDANT CONTAINING PARTICLES AND METHODS OF USE | DAVIS, RUTH A | 1699 | §103§112DP | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18555381 | SYSTEMS, APPARATUS AND METHODS FOR DETERMINING ANEURYSM AND ARTERIAL WALL ENHANCEMENT | MALDONADO, STEVEN | 3797 | §102§103§112 | Final Rejection | 36d overdue | Pending | Oct 13, 2023 |
| 17772450 | FORMULATION FOR DELIVERY OF LUBRICIN GENE | NGUYEN, QUANG | 1631 | §103§112 | Final Rejection | — | Pending | Apr 27, 2022 |
| 17436042 | COMPOSITION COMPRISING AN ANTI-OXIDANT TO PRESERVE CORNEAL TISSUE | RAMOS LEWIS, JOSMALEN MILAGROS | 1621 | §103 | Final Rejection | 34d | Pending | Sep 02, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial